Trial site
Las Vegas Medical Research
- 14running trials
- 17closed trials
The trials here
What the 31 trials at this site are about, from their registry records.
- Conditions
- Obesity13 trials
- Alzheimer disease9 trials
- Type 2 diabetes7 trials
- Crohn's disease3 trials
- Mild cognitive impairment3 trials
- Ulcerative colitis3 trials
- Chronic kidney disease1 trial
- Diabetic neuropathy1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- Irritable bowel syndrome1 trial
- Obstructive sleep apnoea1 trial
- Phase
- Phase 216 trials
- Phase 311 trials
- Phase 2/32 trials
- Status
- Completed13 trials
- Active, not recruiting9 trials
- Terminated4 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company18 trials
- Janssen Research & Development, LLC4 trials
- Biogen2 trials
- Cognito Therapeutics, Inc.2 trials
- Takeda2 trials
- and 3 more
Running trials
Not yet recruiting
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Active, not recruiting
A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis
Active, not recruiting
A Study to Confirm Safety and Efficacy of Lecanemab in Participants With Early Alzheimer's Disease
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes2 recruiting
- Alzheimer disease1 recruiting
- Crohn's disease1 recruiting
- Mild cognitive impairment1 recruiting
Closed trials
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Completed
Completed
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Terminated
Completed
A Study of LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain
Completed
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
Completed
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Completed
A Study of Remternetug (LY3372993) in Participants With Alzheimer's Disease (TRAILRUNNER-ALZ 1)
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
Completed
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Terminated
Site data: ClinicalTrials.govUpdated 15 Nov 2026